Treatment of cancer
AssigneeThe University of Manchester
InventorsKevin Flower, Alan McGown
Life of this patent
Estimating the term…
Abstract
The invention relates to the treatment of cancers, in particular, cancers that are resistant to platinum based chemotherapeutic agents. A pharmaceutical composition for the treatment of cancer comprising an effective amount of a compound having two gold(I) atoms each covalently bonded to a carbon atom in a covalent link connecting the two gold(I) atoms and a pharmaceutically acceptable excipient.
Claims2
A pharmaceutical composition for the treatment of cancer comprising an effective amount of a compound selected from the group consisting of:
- a pharmaceutically acceptable excipient.
A pharmaceutical composition for the treatment of cancer comprising
- an effective amount of a compound having the formula:
- where:
- L and L′ are PPh3;
- R′ and R″ are each independently selected from the group consisting of methylene, ethylene, propylene, butylene and phenylene groups;
- a is 0 to 3;
- b is 0 to 3;
- R′″ is H;
- and
- a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.